Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer
- 1 May 1996
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 73 (10) , 1248-1254
- https://doi.org/10.1038/bjc.1996.239
Abstract
Risk of death and risk of recurrence in 108 potentially curable non-small-cell lung cancer patients were analysed with respect of TNM stage, histological type and carcinoembryonic antigen (CEA), CA125 antigen and squamous cell carcinoma antigen (SCC) levels in serum and cytosol. CA125 and CEA levels were closely related to outcome figures. Multivariate analyses indicated that TNM stage and histological type had the best predictive power, but serum and cytosolic CA125 and serum CEA contained additional, independent prognostic information. Predictive information drawn from serum and cytosolic levels proved mutually complementary. We conclude that CA125 and CEA complement TNM classification and histological type for the purpose of quantifying risk of death or recurrence.Keywords
This publication has 18 references indexed in Scilit:
- Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.Journal of Clinical Oncology, 1995
- Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictorCancer, 1995
- Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancerThe International Journal of Biological Markers, 1995
- The future of prognostic factors in outcome prediction for patients with cancerCancer, 1992
- Prognostic Factors in Lung CancerNew England Journal of Medicine, 1992
- Lung cancer biologyEuropean Journal of Cancer and Clinical Oncology, 1991
- Surgical Treatment of Lung CancerChest, 1991
- A New International Staging System for Lung CancerChest, 1986
- Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapyCancer, 1986
- Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study GroupCancer, 1984